On track to implant first patients in long-term, multicenter feasibility study of the fully implantable continuous blood glucose monitor (CBGM) system in Australia in Q3 2025 Investigational Device Ex ...

Net Loss: Net loss for the first quarter of 2025 was $6.8 million compared to a net loss of $2.9 million for the first quarter of 2024. The increase in net loss is attributable primarily to the ...

Discover 5 powerful diet changes that can reverse prediabetes naturally. Learn which foods stabilize blood sugar and prevent progression to type 2 diabetes.